HALICON 2017

The overall market for genomic testing is estimated at $8B, growing at a CAGR of 15% to 30%.  Significant advances in the technology and clinical techniques used to read genomes enable more genetic information to be read at lower costs, offering the promise of precision medicine.  The market is currently undergoing a  transition from traditional single gene or small gene panel tests to whole exome sequencing (WES) and whole genome sequencing (WGS). The market for genomic testing in the U.S. is a highly fragmented and little homogeneity in testing techniques.